Financial Information of Asston Pharmaceuticals Limited IPO
The Revenues from operations for the Period ended on May 31, 2025 and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 620.93, ₹ 2,561.02 Lakh, ₹ 1,584.09 Lakh and ₹ 719.19 Lakh. The EBITDA for the Period ended on May 31, 2025 and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 194.90, ₹ 673.03 Lakh, ₹
280.06 Lakh and ₹ 217.05 Lakh. The Profit after Tax for the Period ended on May 31, 2025 and Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹ 132.24, ₹
432.51 Lakh, ₹ 136.03 Lakh and ₹ 105.66 Lakh respectively. This indicates a steady growth in financial performance.
Period Ended | May 31, 2025 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 |
---|---|---|---|---|
Reserve of Surplus | 576.87 | 444.63 | 560.86 | 128.59 |
Total Assets | 3,183.43 | 2,812.26 | 2,026.02 | 1,369.42 |
Total Borrowings | 783.28 | 725.72 | 681.99 | 524.51 |
Fixed Assets | 93.44 | 95.56 | 109.10 | 113.14 |
Cash | 21.50 | 19.91 | 0.64 | 12.37 |
Net Borrowing | 761.78 | 705.81 | 681.35 | 512.14 |
Revenue | 620.93 | 2,561.02 | 1,584.09 | 719.19 |
EBITDA | 194.90 | 673.03 | 280.06 | 217.05 |
PAT | 132.24 | 432.51 | 136.03 | 105.66 |
EPS | 2.11 | 6.9 | 2.37 | 1.89 |
Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2025 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Stock Market Masterclass
Equity Investment with CA Abhay
FNO Stocks with CA Abhay
Equity Trading with CA Abhay
Option Trading with CA Abhay
Stock Market Masterclass
Equity Investment with CA Abhay
Option Trading with CA Abhay
FNO Stocks with CA Abhay
Equity Trading with CA Abhay
Copyright @2020 Design & Developed by Info Web Software